FDA Approves First Cellular Therapy to Treat Patients with Unresectable or Metastatic Melanoma

A Boxed Warning is included in the label containing information about these risks. Patients receiving this product should be closely monitored before and after infusion for signs and symptoms of adverse reactions. Treatment should be withheld or discontinued in the presence of these symptoms, as indicated. Amtagvi is a tumor-derived autologous T cell immunotherapy composed […]

error: Not allowed !!